Serum pentraxin 3 levels in rheumatoid arthritis patients and its association with disease activity

Serum pentraxin 3 levels in rheumatoid arthritis patients and its association with disease activity


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: محمد رضا جعفری نخجوانی , امیر قربانی حق جو , الیار پور قاسم , سیما عابدی آذر , طلا پورلک , آیدا مالک مهدوی

کلمات کلیدی: Rheumatoid arthritis, PTX3 protein, Disease activity, DAS28, Biomarkers, Inflammation

نشریه: 43902 , 4 , 41 , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله آیدا مالک مهدوی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه بیماری های بافت همبند
کد مقاله 69503
عنوان فارسی مقاله Serum pentraxin 3 levels in rheumatoid arthritis patients and its association with disease activity
عنوان لاتین مقاله Serum pentraxin 3 levels in rheumatoid arthritis patients and its association with disease activity
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Aim of the work: This work aimed to evaluate serum pentraxin 3 (PTX3) levels in rheumatoid arthritis (RA) patients and to study the association with the disease activity. Patients and methods: Sixty RA patients and 26 matched controls were included. In patients, clinical examination was performed and disease activity score (DAS28) assessed. Serum PTX3, rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were measured. Results: The mean age of the patients was 54.9 ± 11.7 years, and the median (Min–Max) of disease duration was 24 (3.96–60) months and 91.7% were females. The mean DAS28 was 4.16 ± 1.77, the ESR was 38.6 ± 23.03 mm/1st h, CRP was 14.9 ± 8.6 mg/l, RF was 49.6 ± 28.1 IU/ml and the median anti-CCP was 375. Serum PTX3 level was significantly higher in RA patients (2.82 ± 0.48 pg/ml) compared to controls (2.56 ± 0.29 pg/ml) (p = 0.003). There was a significant difference in serum PTX3 level according to the disease activity: remission (2.49 ± 0.16 pg/ml), low (2.61 ± 0.33 pg/ml), moderate (2.90 ± 0.53 pg/ml) and high (3.01 ± 0.51 pg/ml) (p = 0.016). There was a significant correlation between serum PTX3 level with disease activity (r = 0.39, p = 0.002) and CRP (r = 0.49, p < 0.001). There was no significant correlation between serum PTX3 level and the RF (r = 0.25, p = 0.054), anti-CCP (r = 0.18, p = 0.17) and ESR (r = 0.09, p = 0.51). PTX3 and CRP showed a good sensitivity and specificity in predicting RA disease (p = 0.006 and p < 0.001, respectively). Conclusion: PTX3 can be considered as a marker of a positive acute phase response and may serve as a potential novel biomarker for detecting RA activity.  2018 Egyptian Society of Rheumatic Diseases. Publishing services provided by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

نویسندگان
hide/show

نویسنده نفر چندم مقاله
محمد رضا جعفری نخجوانیاول
امیر قربانی حق جودوم
الیار پور قاسمسوم
سیما عابدی آذرچهارم
طلا پورلکپنجم
آیدا مالک مهدویششم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Serum pentraxin 3 levels in rheumatoid arthritis patients and its.pdf1398/08/02652356دانلود